Dermatology NewsCell-killing cancer therapy treats lupus successfullySeptember 22, 2022Autoimmune Diseases
Dermatology NewsLitifilimab meets primary endpoint in phase 2 lupus trialSeptember 13, 2022Autoimmune Diseases
Dermatology NewsInhaled, systemic steroids linked to changes in brain structureAugust 31, 2022Autoimmune DiseasesMixed TopicsPsoriatic Arthritis
Dermatology NewsAnti-BDCA2 antibody meets primary endpoint in phase 2 cutaneous lupus trialAugust 5, 2022Autoimmune Diseases
Dermatology NewsNo more ‘escape hatch’: Post Roe, new worries about meds linked to birth defectsJune 29, 2022Psoriatic ArthritisPediatricsAutoimmune Diseases
Dermatology NewsAutoimmune disease linked to better late-stage breast cancer survivalJune 14, 2022Autoimmune DiseasesPsoriasis
Dermatology NewsDeucravacitinib and orelabrutinib perform well in early lupus trialsJune 10, 2022Autoimmune Diseases
Dermatology NewsLupus mutation may unlock targeted drugs for patient subsetJune 3, 2022Autoimmune Diseases
Pemphigus Vulgaris Aggravated: Rifampicin Found at the Scene of the CrimeMay 25, 2022Autoimmune Diseases
Dermatology NewsLenabasum improved skin symptoms in dermatomyositis, but future is uncertainMay 17, 2022Autoimmune DiseasesMixed Topics
